Simvastatin is indicated for preventing cardiovascular disease in high-risk patients and for treating dyslipidemia and hypercholesteremia.
Unipharm’s generic Simvastatin Tablets have been manufactured and marketed in Israel since 2001.
ATC4: C10AA
Strengths: 10, 20, 40 & 80 mg
Dosage form: Tablets
Out-licensing is offered for all international markets*
Zone IVb stability data is available
* Product availability is subject to patent restrictions in countries where applicable patents are in effect
